StratDeck

Two stocks in Healthcare

Abbott Laboratories vs Amgen: profit, growth, debt and price compared

Abbott Laboratories is stronger on 5 of 7 figures: sales growth, debt, price for its expected profit, dividend and analysts' view. Amgen is stronger on 2: profit margin and price trend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Abbott Laboratories' storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Abbott Laboratories and Amgen side by side
Abbott LaboratoriesABTAmgenAMGN
Net margin9.8%Stronger: 24.1%
Revenue growth, past yearStronger: +14.46%+8.45%
Debt to equityStronger: 60.9%376.3%
Forward P/EStronger: 17.6×17.7×
Dividend yieldStronger: 2.41%2.27%
AnalystsStronger: Buy · 26Hold · 29
From its 200-day average0.0%Stronger: +14.8%

Share price over the past year

  • Abbott Laboratories−19.6%
  • Amgen+29.0%

18 Nov 202518 Nov 2026

Abbott Laboratories or Amgen: which is stronger?

  • AMGN

    Which is more profitable?

    Amgen keeps more of each sale as profit: 24.1% against 9.8%.

  • ABT

    Which is growing its sales faster?

    Abbott Laboratories is growing its sales faster: +14.46% over the past year, against +8.45%.

  • ABT

    Which has borrowed less?

    Abbott Laboratories has borrowed less: its debt is 60.9% of what its shareholders own, against 376.3% for Amgen.

  • ABT

    Which costs less for the profit it is expected to make?

    Abbott Laboratories costs less for the profit it is expected to make: 17.6× its forward earnings, against 17.7×.

  • ABT

    Which pays more in dividends?

    Abbott Laboratories pays more back in dividends for what a share costs: 2.41% a year, against 2.27%.

  • ABT

    Which do analysts rate higher?

    Analysts are warmer on Abbott Laboratories: Buy, against Hold for Amgen.

  • AMGN

    Which is in the stronger price trend?

    Amgen's price is in the stronger trend: 14.8% above its 200-day average, against 0.0% above.

What each company does

ABTAbbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.

Reports results on 28 January 2027

AMGNAmgen

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Reports results on 2 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.